SlideShare a Scribd company logo
2
Most read
5
Most read
6
Most read
CHAPTER 3
WHAT IS CLEARANCE?
‘Clearance’ describes the efficiency of irreversible elimination of a
drug from the systemic circulation. Elimination in this context refers
to the excretion of the unchanged drug into urine, gut contents,
expired air, sweat, etc., and to the metabolic conversion of the drug
into a different chemical compound, predominantly in the liver, but
also to a small extent in other organs. When the drug has been
metabolised, the parent drug has been cleared or eliminated, even
though the metabolite may still be in the body. Uptake of the drug
into tissues is not clearance if the unchanged drug eventually comes
back out of the tissue, however slowly this occurs.
Clearance is defined as ‘the volume of blood cleared of drug per
unit time’ and the units are thus volume per time, usually litres per
hour or mL per minute. We can refer to clearance by a particular
organ, such as liver or kidney, by a particular metabolic pathway, or
by the whole body. Total body clearance is the sum of all the different
clearance processes occurring for a given drug.
Let’s consider an example. What does it mean if the clearance of a
particular drug by the liver is 60 L/hour and liver blood flow (QH
) is
90 L/hour? It does not mean that 60 L of blood going through the
liver is totally cleared of the drug and the next 30 L is not cleared at
all. Rather, it means that two-thirds (60/90) of the drug entering the
liver in the blood is irreversibly removed by the liver (cleared) in one
pass through the liver. The drug that is extracted from the blood
is metabolised in the liver cell so that the parent compound is
eliminated. The value of two-thirds for this drug is called the
CLEARANCE
CHAPTER 1
1
rkett 2e CH1.indd 1rkett 2e CH1.indd 1 26/11/09 3:06:07 PM26/11/09 3:06:07 PM
2 Pocket Guide: Pharmacokinetics Made Easy
extraction ratio and is simply one minus the ratio of concentration of
drug in blood leaving the liver to that in blood entering the liver.
extraction ratio (EH
) = 1 –
concentration out
concentration in
Equation 1.1
It will be apparent from the above that clearance is determined by
the blood flow to an eliminating organ (QH
in the case of the liver)
and the efficiency of irreversible drug extraction from the blood by
the organ (EH
). This is considered further in Chapter 4.
Obviously, the most drug that could be removed by the liver is all
that enters the organ. In this case, the ‘concentration out’ would be
0.0, extraction ratio would be 1.0 and the hepatic clearance 90 L/hour.
The further significance of the extraction ratio will be discussed in
Chapter 4. For the present, it should be noted that the minimum
clearance by an organ is zero and the maximum clearance by an
organ is the blood flow to the organ.
CLEARANCE AND ELIMINATION
RATE
Another definition of clearance is that it is the constant relating the
concentration of drug in the plasma to the rate at which the drug is
eliminated from the body.
elimination rate = clearance (CL) ∗ plasma drug concentration (C)
(mg/hour) (L/hour) (mg/L)
Equation 1.2
It is apparent that for a given clearance, which is a constant char-
acteristic of a particular drug and a particular patient, the elimination
rate varies directly with the plasma drug concentration.
WHY IS CLEARANCE IMPORTANT?
Clearance is the one parameter that determines the maintenance
dose rate required to achieve a target plasma concentration (and
therefore effect) at steady state. Steady state is defined as the
situation at which the rate of drug administration is equal to the rate
of drug elimination so that the amount of drug in the body, and
rkett 2e CH1.indd 2rkett 2e CH1.indd 2 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
Chapter 1 Clearance 3
1
therefore the plasma drug concentration, remains constant. At
steady state,
elimination rate = maintenance dose rate (DR)
Equation 1.3
From Equations 1.2 and 1.3, the maintenance dose rate required to
achieve a target steady state plasma drug concentration can be
calculated as:
maintenance dose rate (DR) = clearance (CL)∗steady state drug
concentration (Css
)
(mg/hour) (L/hour) (mg/L)
Equation 1.4
This is illustrated in Figure 1.1 (following page) for constant rate
intravenous infusions of two drugs, for one of which the clearance is
double that of the other. Note that, with a constant infusion, the
plasma drug concentration rises steadily until it eventually reaches a
plateau or steady state when the rate of drug administration equals
the rate of drug elimination.
The oral dosing situation is slightly more complex because the
drug concentration fluctuates during the dosing interval as the drug
is absorbed and eliminated. Eventually, however, the amount of
drug eliminated during the dosing interval equals the dose admin-
istered, and the drug concentrations then fluctuate over the same
range during each dosing interval; that is, steady state has been
reached. At this point, the average drug concentration over the dosing
interval is the same as the steady state plasma concentration for a
constant intravenous infusion at the same dose rate. From Equation
1.4, it is easy to see that, for a given dose rate, the plasma drug con-
centration is inversely proportional to clearance. For example, if the
clearance is reduced by half, the steady state concentration will
double (see Figure 1.1).
HOW IS CLEARANCE MEASURED?
The classical method of measuring renal clearance (e.g. of creatinine
or drugs) is to measure the rate of excretion in urine, and the
blood concentration at the same time. This is the well-known
CL = U∗V/P relationship where U is urine drug concentration, V is
urine flow rate and P is the plasma (or blood) concentration of a
rkett 2e CH1.indd 3rkett 2e CH1.indd 3 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
4 Pocket Guide: Pharmacokinetics Made Easy
solute such as creatinine or a drug. This is actually the same as
Equation 1.2, as U∗V is the excretion rate of the solute or drug.
To obtain total body clearance of a drug from the systemic
circulation, we can use Equation 1.4 to obtain clearance from the
steady state drug concentration during a constant intravenous
infusion.
dose rate
clearance =
steady state plasma concentration
CL =
DR
Css
Equation 1.5
Alternatively, we can take frequent blood samples after a single
intravenous dose, measure the drug concentration in each, and
calculate the area under the drug concentration versus time curve
(AUC) (see Figure 1.2 on page 6). Then:
Drugconcentration(mg/L)
Drug A: CL = 5 L/hour
Drug B: CL = 10 L/hour
2.0
1.5
1.0
0.5
0 5 10 15 20 25 30
Time (hours)
Figure 1.1: Effect of clearance on steady state drug concentration time
profile
Clearance determines the plasma drug concentration at steady state. For both
drugs A and B, the dose rate is 10 mg/hour.
rkett 2e CH1.indd 4rkett 2e CH1.indd 4 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
Chapter 1 Clearance 5
1
dose
clearance =
AUCN
(L/hour)
mg
mg∗hour/L
Equation 1.6
From this relationship, it can be seen that the total area under the
plasma concentration time curve after a single intravenous dose is,
like the steady state concentration, only determined by the dose and
the clearance.
PLASMA OR BLOOD DRUG
CONCENTRATIONS?
It is the convention in pharmacokinetics to use plasma concentra-
tions of drugs as this is what is usually measured in the laboratory.
Measuring whole blood concentrations tends to be more difficult due
to the presence of more interfering compounds. Therefore, throughout
this book, pharmacokinetic parameters will be referred to in terms of
plasma drug concentrations. It should be remembered, however, that
the tissues and eliminating organs such as the kidneys and liver are
perfused with blood, not plasma. The plasma concentration of a drug
can be related to the whole blood concentration by the blood:plasma
concentration ratio (λ).
λ =
drug concentration in whole blood
=
Cb
drug concentration in plasma C
Cb
= C∗λ
Equation 1.7
This ratio is usually close to 1.0 as the drug concentrations in the
cellular and plasma components of blood are usually about the same.
The ratio cannot be less than about 0.5 (the haematocrit). It can,
however, be quite large for highly lipophilic drugs like cyclosporin
and chloroquine which are relatively concentrated in the red cells.
In such cases, it is better to express clearance and volume of distribu-
tion in terms of drug concentrations in whole blood rather than
in plasma.
rkett 2e CH1.indd 5rkett 2e CH1.indd 5 26/11/09 3:06:09 PM26/11/09 3:06:09 PM
6 Pocket Guide: Pharmacokinetics Made Easy
KEY POINTS
Clearance is the fundamental pharmacokinetic parameter that is a•
measure of the efficiency of drug elimination.
Clearance is the volume of blood cleared of drug per unit time and•
is the proportionality constant between plasma drug concentra-
tion and elimination rate.
For a given intravenous maintenance dose rate, clearance is the•
sole parameter determining the steady state drug concentration.
Drugconcentration(mg/L)
Time (hours)
12
10
8
6
4
2 Area under the curve (AUC)
(mg*hour/L)
0 4 8 12 16 20 24
Figure 1.2: Measurement of clearance
Clearance can be determined by measuring plasma drug concentrations at multiple
times after a single intravenous bolus dose. The AUC can be estimated by assum-
ing each pair of drug concentration time observations form a trapezoid. The area of
each trapezoid is calculated then summed.
dose (mg)
CL(L/hour) =
AUC(mg∗hour/L)
rkett 2e CH1.indd 6rkett 2e CH1.indd 6 26/11/09 3:06:09 PM26/11/09 3:06:09 PM
Chapter 1 Clearance 7
1
SELF-TEST QUESTIONS
(Note: There may be multiple correct options.)
1. Elimination of a drug refers to:
excretion of its breakdown products in the urinea)
renal excretion of the unchanged drugb)
uptake of drug from the blood into the liverc)
metabolism of the drug in the liverd)
distribution of the drug into fate)
2. The elimination rate of a drug is:
a constant for a particular drug and patienta)
the extent to which it is excreted in urineb)
directly proportional to the plasma drug concentrationc)
directly proportional to the clearanced)
the extent to which the drug is excreted in the faecese)
3. Clearance:
depends on the elimination ratea)
refers to the efficiency of elimination of drug by an organ orb)
the whole body
cannot be greater than blood flow to an organ (CLc) H
cannot
be greater than QH
but total CL can)
determines the steady state drug concentration duringd)
constant dosing
is determined by the half-lifee)
4. Two definitions of clearance are:
the volume of blood or plasma irreversibly cleared of drug pera)
unit time
the time taken to reduce the plasma concentration by halfb)
the constant relating the rate of elimination of a drug to thec)
plasma drug concentration
the amount of drug metabolised per unit timed)
the amount of drug excreted in urine per unit timee)
rkett 2e CH1.indd 7rkett 2e CH1.indd 7 26/11/09 3:06:09 PM26/11/09 3:06:09 PM

More Related Content

PPTX
Factors affecting pharmacokinetic parameters
PPTX
DIGOXIN: Therapeutic Drug Monitoring
PPT
Drugs acting on uterus - drdhriti
PPTX
Identify and Describe The Management of Drug Interactions
PPTX
Non compartment model
PPTX
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by akt
PPTX
Digitalis nikku ppt
PPTX
Distribution of drugs
Factors affecting pharmacokinetic parameters
DIGOXIN: Therapeutic Drug Monitoring
Drugs acting on uterus - drdhriti
Identify and Describe The Management of Drug Interactions
Non compartment model
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by akt
Digitalis nikku ppt
Distribution of drugs

What's hot (20)

PPTX
Drugs action on uterus
PPT
dosage adjustment in renal and hepatic failure for medical student
PDF
Liquorice (glycyrrhiza glabra linn.)
PPTX
Concept of clearance & factors affecting renal excretion
PPTX
Barbiturate poisoning
PPTX
PPTX
Diuretic drugs
PPT
Lecture 2 adithan diuretics july 29, 2016 mgmcri
PPTX
Alkylating agents
PPTX
Drug drug interaction
PPTX
Loading dose plus iv infusion
PDF
Dose adjustment in renal disease
PPTX
Diuretics II
PPTX
Digoxin toxicity
PPTX
Dosing in elderly
PPTX
clinical pharmacokinetics
PPTX
Drugs used in Congestive heart failure
PPTX
Cultivation, Collection and T.S , Powder Character Wood (Quassia) Flower (Clo...
PPTX
Use of computers in hospital pharmacy, biostatistics and research methodology...
PPTX
Presentation1
Drugs action on uterus
dosage adjustment in renal and hepatic failure for medical student
Liquorice (glycyrrhiza glabra linn.)
Concept of clearance & factors affecting renal excretion
Barbiturate poisoning
Diuretic drugs
Lecture 2 adithan diuretics july 29, 2016 mgmcri
Alkylating agents
Drug drug interaction
Loading dose plus iv infusion
Dose adjustment in renal disease
Diuretics II
Digoxin toxicity
Dosing in elderly
clinical pharmacokinetics
Drugs used in Congestive heart failure
Cultivation, Collection and T.S , Powder Character Wood (Quassia) Flower (Clo...
Use of computers in hospital pharmacy, biostatistics and research methodology...
Presentation1
Ad

Viewers also liked (20)

PDF
What is storytelling and how can narratives contribute to regional development
DOCX
DOCX
U2 practica 8
DOC
Resume_Manabrata_Maity_2_Years_Experience
PPS
Cary Nadler, Phd.
PPTX
Field journal geo 5
DOC
Strategies
PDF
Taxing times
PPTX
Why recruit@vgsom
PPTX
Kenwood T9450MT12-ECN
DOCX
Kccl final report by majid khan
PPTX
Final project presentation
PDF
Perry mistry prospecsv.org_1_cleantechmanufacturing-in-sanjose
PDF
Plots in Neemrana-ashu Group,8459137252
PPT
Mori involvementandconsultation
PPT
PPT
Compare Nation Food Prices
PPTX
Emily's Bug Book
PPT
Censorship quotes
PPTX
презентация электронного курса э.ф.
What is storytelling and how can narratives contribute to regional development
U2 practica 8
Resume_Manabrata_Maity_2_Years_Experience
Cary Nadler, Phd.
Field journal geo 5
Strategies
Taxing times
Why recruit@vgsom
Kenwood T9450MT12-ECN
Kccl final report by majid khan
Final project presentation
Perry mistry prospecsv.org_1_cleantechmanufacturing-in-sanjose
Plots in Neemrana-ashu Group,8459137252
Mori involvementandconsultation
Compare Nation Food Prices
Emily's Bug Book
Censorship quotes
презентация электронного курса э.ф.
Ad

Similar to Pocket Guide: Pharmacokinetics Made Easy - sample (20)

PPTX
Pharmacokinetics ppt
PPTX
Pharmacokinetics ppt
PPTX
Clinical PK UOB moodle.pptxdfffssssssssssssssssssssssssssssssss
PPTX
Renal clearance
PDF
Pharmacokinetics: Lecture Three
PPTX
Clearance of drugs in anesthesiology.pptx
PPTX
One Compartment Open Model (IV Bolus) B pharm , M pharm
PPTX
ONE COMPARTMENT MODEL.pptx
PPTX
Pharmacokinetics Parameters by NOVATUS CHING'ORO, MUHAS.
PPT
Kinetika En 2002
PPT
Kinetika En 2002
PPTX
Lec 3.2-hepatic elimination (clearance of protien bound drugs) (1)
PPTX
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
PPTX
Renal clearance
PDF
Overview of Pharmacokinetic Parameters.pdf
PPTX
Clinical pharmacokinetics
PPTX
kinetics.pptx
PPT
one compartment open model
PPTX
Drug Clearance
PPTX
Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021
Pharmacokinetics ppt
Pharmacokinetics ppt
Clinical PK UOB moodle.pptxdfffssssssssssssssssssssssssssssssss
Renal clearance
Pharmacokinetics: Lecture Three
Clearance of drugs in anesthesiology.pptx
One Compartment Open Model (IV Bolus) B pharm , M pharm
ONE COMPARTMENT MODEL.pptx
Pharmacokinetics Parameters by NOVATUS CHING'ORO, MUHAS.
Kinetika En 2002
Kinetika En 2002
Lec 3.2-hepatic elimination (clearance of protien bound drugs) (1)
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
Renal clearance
Overview of Pharmacokinetic Parameters.pdf
Clinical pharmacokinetics
kinetics.pptx
one compartment open model
Drug Clearance
Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021

Recently uploaded (20)

PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
Acid Base Disorders educational power point.pptx
PPTX
Note on Abortion.pptx for the student note
PPTX
Slider: TOC sampling methods for cleaning validation
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PPTX
Imaging of parasitic D. Case Discussions.pptx
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
Gastroschisis- Clinical Overview 18112311
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPTX
SKIN Anatomy and physiology and associated diseases
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
CT Anatomy for Radiotherapy.pdf eryuioooop
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Acid Base Disorders educational power point.pptx
Note on Abortion.pptx for the student note
Slider: TOC sampling methods for cleaning validation
OPIOID ANALGESICS AND THEIR IMPLICATIONS
History and examination of abdomen, & pelvis .pptx
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
Khadir.pdf Acacia catechu drug Ayurvedic medicine
Imaging of parasitic D. Case Discussions.pptx
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Obstructive sleep apnea in orthodontics treatment
Gastroschisis- Clinical Overview 18112311
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
SKIN Anatomy and physiology and associated diseases
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects

Pocket Guide: Pharmacokinetics Made Easy - sample

  • 1. CHAPTER 3 WHAT IS CLEARANCE? ‘Clearance’ describes the efficiency of irreversible elimination of a drug from the systemic circulation. Elimination in this context refers to the excretion of the unchanged drug into urine, gut contents, expired air, sweat, etc., and to the metabolic conversion of the drug into a different chemical compound, predominantly in the liver, but also to a small extent in other organs. When the drug has been metabolised, the parent drug has been cleared or eliminated, even though the metabolite may still be in the body. Uptake of the drug into tissues is not clearance if the unchanged drug eventually comes back out of the tissue, however slowly this occurs. Clearance is defined as ‘the volume of blood cleared of drug per unit time’ and the units are thus volume per time, usually litres per hour or mL per minute. We can refer to clearance by a particular organ, such as liver or kidney, by a particular metabolic pathway, or by the whole body. Total body clearance is the sum of all the different clearance processes occurring for a given drug. Let’s consider an example. What does it mean if the clearance of a particular drug by the liver is 60 L/hour and liver blood flow (QH ) is 90 L/hour? It does not mean that 60 L of blood going through the liver is totally cleared of the drug and the next 30 L is not cleared at all. Rather, it means that two-thirds (60/90) of the drug entering the liver in the blood is irreversibly removed by the liver (cleared) in one pass through the liver. The drug that is extracted from the blood is metabolised in the liver cell so that the parent compound is eliminated. The value of two-thirds for this drug is called the CLEARANCE CHAPTER 1 1 rkett 2e CH1.indd 1rkett 2e CH1.indd 1 26/11/09 3:06:07 PM26/11/09 3:06:07 PM
  • 2. 2 Pocket Guide: Pharmacokinetics Made Easy extraction ratio and is simply one minus the ratio of concentration of drug in blood leaving the liver to that in blood entering the liver. extraction ratio (EH ) = 1 – concentration out concentration in Equation 1.1 It will be apparent from the above that clearance is determined by the blood flow to an eliminating organ (QH in the case of the liver) and the efficiency of irreversible drug extraction from the blood by the organ (EH ). This is considered further in Chapter 4. Obviously, the most drug that could be removed by the liver is all that enters the organ. In this case, the ‘concentration out’ would be 0.0, extraction ratio would be 1.0 and the hepatic clearance 90 L/hour. The further significance of the extraction ratio will be discussed in Chapter 4. For the present, it should be noted that the minimum clearance by an organ is zero and the maximum clearance by an organ is the blood flow to the organ. CLEARANCE AND ELIMINATION RATE Another definition of clearance is that it is the constant relating the concentration of drug in the plasma to the rate at which the drug is eliminated from the body. elimination rate = clearance (CL) ∗ plasma drug concentration (C) (mg/hour) (L/hour) (mg/L) Equation 1.2 It is apparent that for a given clearance, which is a constant char- acteristic of a particular drug and a particular patient, the elimination rate varies directly with the plasma drug concentration. WHY IS CLEARANCE IMPORTANT? Clearance is the one parameter that determines the maintenance dose rate required to achieve a target plasma concentration (and therefore effect) at steady state. Steady state is defined as the situation at which the rate of drug administration is equal to the rate of drug elimination so that the amount of drug in the body, and rkett 2e CH1.indd 2rkett 2e CH1.indd 2 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
  • 3. Chapter 1 Clearance 3 1 therefore the plasma drug concentration, remains constant. At steady state, elimination rate = maintenance dose rate (DR) Equation 1.3 From Equations 1.2 and 1.3, the maintenance dose rate required to achieve a target steady state plasma drug concentration can be calculated as: maintenance dose rate (DR) = clearance (CL)∗steady state drug concentration (Css ) (mg/hour) (L/hour) (mg/L) Equation 1.4 This is illustrated in Figure 1.1 (following page) for constant rate intravenous infusions of two drugs, for one of which the clearance is double that of the other. Note that, with a constant infusion, the plasma drug concentration rises steadily until it eventually reaches a plateau or steady state when the rate of drug administration equals the rate of drug elimination. The oral dosing situation is slightly more complex because the drug concentration fluctuates during the dosing interval as the drug is absorbed and eliminated. Eventually, however, the amount of drug eliminated during the dosing interval equals the dose admin- istered, and the drug concentrations then fluctuate over the same range during each dosing interval; that is, steady state has been reached. At this point, the average drug concentration over the dosing interval is the same as the steady state plasma concentration for a constant intravenous infusion at the same dose rate. From Equation 1.4, it is easy to see that, for a given dose rate, the plasma drug con- centration is inversely proportional to clearance. For example, if the clearance is reduced by half, the steady state concentration will double (see Figure 1.1). HOW IS CLEARANCE MEASURED? The classical method of measuring renal clearance (e.g. of creatinine or drugs) is to measure the rate of excretion in urine, and the blood concentration at the same time. This is the well-known CL = U∗V/P relationship where U is urine drug concentration, V is urine flow rate and P is the plasma (or blood) concentration of a rkett 2e CH1.indd 3rkett 2e CH1.indd 3 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
  • 4. 4 Pocket Guide: Pharmacokinetics Made Easy solute such as creatinine or a drug. This is actually the same as Equation 1.2, as U∗V is the excretion rate of the solute or drug. To obtain total body clearance of a drug from the systemic circulation, we can use Equation 1.4 to obtain clearance from the steady state drug concentration during a constant intravenous infusion. dose rate clearance = steady state plasma concentration CL = DR Css Equation 1.5 Alternatively, we can take frequent blood samples after a single intravenous dose, measure the drug concentration in each, and calculate the area under the drug concentration versus time curve (AUC) (see Figure 1.2 on page 6). Then: Drugconcentration(mg/L) Drug A: CL = 5 L/hour Drug B: CL = 10 L/hour 2.0 1.5 1.0 0.5 0 5 10 15 20 25 30 Time (hours) Figure 1.1: Effect of clearance on steady state drug concentration time profile Clearance determines the plasma drug concentration at steady state. For both drugs A and B, the dose rate is 10 mg/hour. rkett 2e CH1.indd 4rkett 2e CH1.indd 4 26/11/09 3:06:08 PM26/11/09 3:06:08 PM
  • 5. Chapter 1 Clearance 5 1 dose clearance = AUCN (L/hour) mg mg∗hour/L Equation 1.6 From this relationship, it can be seen that the total area under the plasma concentration time curve after a single intravenous dose is, like the steady state concentration, only determined by the dose and the clearance. PLASMA OR BLOOD DRUG CONCENTRATIONS? It is the convention in pharmacokinetics to use plasma concentra- tions of drugs as this is what is usually measured in the laboratory. Measuring whole blood concentrations tends to be more difficult due to the presence of more interfering compounds. Therefore, throughout this book, pharmacokinetic parameters will be referred to in terms of plasma drug concentrations. It should be remembered, however, that the tissues and eliminating organs such as the kidneys and liver are perfused with blood, not plasma. The plasma concentration of a drug can be related to the whole blood concentration by the blood:plasma concentration ratio (λ). λ = drug concentration in whole blood = Cb drug concentration in plasma C Cb = C∗λ Equation 1.7 This ratio is usually close to 1.0 as the drug concentrations in the cellular and plasma components of blood are usually about the same. The ratio cannot be less than about 0.5 (the haematocrit). It can, however, be quite large for highly lipophilic drugs like cyclosporin and chloroquine which are relatively concentrated in the red cells. In such cases, it is better to express clearance and volume of distribu- tion in terms of drug concentrations in whole blood rather than in plasma. rkett 2e CH1.indd 5rkett 2e CH1.indd 5 26/11/09 3:06:09 PM26/11/09 3:06:09 PM
  • 6. 6 Pocket Guide: Pharmacokinetics Made Easy KEY POINTS Clearance is the fundamental pharmacokinetic parameter that is a• measure of the efficiency of drug elimination. Clearance is the volume of blood cleared of drug per unit time and• is the proportionality constant between plasma drug concentra- tion and elimination rate. For a given intravenous maintenance dose rate, clearance is the• sole parameter determining the steady state drug concentration. Drugconcentration(mg/L) Time (hours) 12 10 8 6 4 2 Area under the curve (AUC) (mg*hour/L) 0 4 8 12 16 20 24 Figure 1.2: Measurement of clearance Clearance can be determined by measuring plasma drug concentrations at multiple times after a single intravenous bolus dose. The AUC can be estimated by assum- ing each pair of drug concentration time observations form a trapezoid. The area of each trapezoid is calculated then summed. dose (mg) CL(L/hour) = AUC(mg∗hour/L) rkett 2e CH1.indd 6rkett 2e CH1.indd 6 26/11/09 3:06:09 PM26/11/09 3:06:09 PM
  • 7. Chapter 1 Clearance 7 1 SELF-TEST QUESTIONS (Note: There may be multiple correct options.) 1. Elimination of a drug refers to: excretion of its breakdown products in the urinea) renal excretion of the unchanged drugb) uptake of drug from the blood into the liverc) metabolism of the drug in the liverd) distribution of the drug into fate) 2. The elimination rate of a drug is: a constant for a particular drug and patienta) the extent to which it is excreted in urineb) directly proportional to the plasma drug concentrationc) directly proportional to the clearanced) the extent to which the drug is excreted in the faecese) 3. Clearance: depends on the elimination ratea) refers to the efficiency of elimination of drug by an organ orb) the whole body cannot be greater than blood flow to an organ (CLc) H cannot be greater than QH but total CL can) determines the steady state drug concentration duringd) constant dosing is determined by the half-lifee) 4. Two definitions of clearance are: the volume of blood or plasma irreversibly cleared of drug pera) unit time the time taken to reduce the plasma concentration by halfb) the constant relating the rate of elimination of a drug to thec) plasma drug concentration the amount of drug metabolised per unit timed) the amount of drug excreted in urine per unit timee) rkett 2e CH1.indd 7rkett 2e CH1.indd 7 26/11/09 3:06:09 PM26/11/09 3:06:09 PM